Serum 25 OH vitamin D concentrations and calcium intake are low in patients with prostate cancer

Endocrinologia y Nutricion

Volumn 58, Issue 9, 2011, Pages 487-491

  Varsavsky, Mariela ^a   Reyes García, Rebeca ^a   Cortés Berdonces, María ^a   García Martin, Antonia ^a   Rozas Moreno, Pedro ^a   Muñoz Torres, Manuel ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

BMD; Calcium intake; Osteoporosis; Prostate cancer; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; BICALUTAMIDE; CALCIUM; FLUTAMIDE; GOSERELIN; LEUPRORELIN; PHOSPHATE; TRIPTORELIN;

AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BONE DENSITY; BONE METASTASIS; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PROSTATE CANCER; QUESTIONNAIRE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

AGED; BONE DENSITY; CALCIUM, DIETARY; CROSS-SECTIONAL STUDIES; HUMANS; MALE; PROSTATIC NEOPLASMS; VITAMIN D;

EID: 82755192958     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2011.07.007     Document Type: Article

References (22)

1. Garland C.F., Garland F.C. Do sunlight and vitamin D reduce the likelihood of colon cancer?. Int J Epidemiol 1980, 9:227-231.
2. Garland C.F., Comstock G.W., Garland F.C., Helsing K.J., Shaw E., Gorham E.D. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2000, 2:1176-1178.
3. Holick M. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
4. Giovannucci E., Liu Y., Rimm E.B., Hollis B.W., Fuchs C.S., Stampfer M.J., et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006, 98:451-459.
5. Zhou W., Heist R.S., Liu G., Asomaning K., Neuberg D.S., Hollis B.W., et al. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 2007, 25:479-485.
6. Quesada J.M., Solana R., Serrano I., Barrio V., Martínez M.E., Santamaría M., et al. Immunologic effects of vitamin D. N Engl J Med 1989, 321:833-834.
7. Adams J.S., Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008, 4:80-90.
8. Beer T.M., Ryan C.W., Venner P.M., Petrylak D.P., Chatta G.S., Ruether J.D., et al. Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators. J Clin Oncol 2007, 25:669-674.
9. Holick M.F. Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol 2006, 92:49-59.
10. Luscombe C.L., Fryer A.A., French M.E. Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet 2001, 358:641-642.
11. Ahn J., Peters U., Albanes D., Purdue M., Abnet C.C., Chatterjee N., et al. Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst 2008, 100:796-804.
12. Tuohimaa P., Tenkanen L., Ahonen M., Lumme S., Jellum E., Hallmans G., et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004, 108:104-108.
13. Jacobs E.T., Giuliano A.R., Martinez M.E., Hollis B.W., Reid M.E., Marshall J.R. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol 2004, 89-90:553-557.
14. Li H., Stampfer M.J., Hollis J.B., Mucci L.A., Gaziano J.M., Hunter D., et al. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. Plos Med 2007, 4:e103.
15. Greenspan S., Coates P., Sereika S.M., Nelson J.B., Trump D.L., Resnick N.M. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab 2005, 90:6410-6417.
16. Cauley J.A., Fullman R.L., Stone K.L., Zmuda J.M., Bauer D.C., Barrett-Connor E., et al. Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int 2005, 16:1525-1537.
17. Planas J., Morote J., Orsola A., Salvador C., Trilla E., Ceccini L., et al. The relationship between daily calcium intake and bone mineral density in men with prostate cancer. BJU Int 2007, 99:812-816.
18. Smith M.R., McGovern F.J., Fallon M.A., Schoenfeld D., Kantoff P.W., Finskelstein J.S. Low bone mineral density in hormone naive men with prostate carcinoma. Cancer 2001, 91:2238-2245.
19. Trump D.L., Chadha M.K., Sung A.Y., Fakih M.G., Ashraf U., Silliman C.G., et al. Vitamin D deficiency and insufficiency among patients with prostate cancer. BJU Int 2009, 104:909-914.
20. Tretli S., Hernes E., Berg J.P., Hestvik U.E., Robsahm T.E. Association between serum 25 (OH) D and death from prostate cancer. Br J Cancer 2009, 100:450-545.
21. Sebring N.G., Denkinger I., Menzie C.M., Yanoff L.B., Parikh S.J., Yanovski J.A. Validation of three food frequency questionnaires to assess dietary calcium intake in adults. J Am Diet Assoc 2007, 10:752-759.
22. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J., Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005, 16:713-716.